MIR3923

Across TCGA pan-cancer cohorts, MIR3923 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR3923 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR3923 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3923 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

ACC, BLCA, and STAD are the cancer types where MIR3923 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.145	0.888	<.001	135	view →
BLCA	OS	Tertile	All	0.082	0.688	<.001	90	view →
STAD	DFS	Tertile	All	0.253	0.723	<.001	54	view →
READ	OS	Tertile	All	0.069	0.917	<.001	36	view →
BRCA	OS	Tertile	All	0.123	0.578	.014	24	view →
OV	DFS	Tertile	III,IV	0.700	0.151	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR3923–ACC (OS)

Open the ACC breakdown →